Skip to main content

and
Your search also matched 11 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study

Include preview-only content
  1. Article

    Open Access

    Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma

    IDH1-mutated cholangiocarcinomas (CCAs) are an interesting group of neoplasia with particular behavior and therapeutic implications. The aim of the present work is to highlight the differences characterizing IDH1

    Margherita Rimini, Carles Fabregat-Franco, Valentina Burgio in Scientific Reports (2022)

  2. Article

    Correction to: Sequential Treatment of Sorafenib–Regorafenib Versus Sorafenib–Physician’s Choice: A Propensity Score-Matched Analysis

    A correction to this paper has been published: https://doi.org/10.1007/s11523-021-00808-3

    Yeonghak Bang, Changhoon Yoo, Sara Lonardi, Hyung-Don Kim in Targeted Oncology (2021)

  3. Article

    Open Access

    Impact of sentinel lymph-node biopsy and FDG-PET in staging and radiation treatment of anal cancer patients

    To assess the role of sentinel lymph-node biopsy (SLNB) and FDG-PET in staging and radiation treatment (RT) of anal cancer patients. This retrospective study was performed on 80 patients (male: 32, female: 48)...

    Najla Slim, Paolo Passoni, Elena Incerti, Roberta Tummineri in Scientific Reports (2020)